GREGORY JULIA P sold 67.7% of their position (22.58K shares) of NURIX THERAPEUTICS, INC. on the open market
Open‑market sale worth $528.5K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 10/14/2026ACC: 0001226675-26-000006
-22.58K
Net shares
Net seller
$528.5K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
22.58K acquired · 45.17K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+22.58K
Price / share
$1.86
Trade value
$42K
% of position
210.1%
10/14/2026
10.75K→33.33K
Common Stock
Direct
Shares
−22.58K
Price / share
$23.40
Trade value
$528.53K
% of position
67.7%
10/14/2026
33.33K→10.75K
Total
Net shares
+0.00
Net value
-$486.52K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/14/2026 | M · Option Exercise | +22.58K | $1.86 | $42K | 210.1% | 10.75K | 33.33K |
| Common Stock Direct | 10/14/2026 | S · Sale | −22.58K | $23.40 | $528.53K | 67.7% | 33.33K | 10.75K |
| Total | +0.00 | -$486.52K | ||||||
Derivative Transactions1
Director Stock Option (right to buy)
Direct
Converts to
Common Stock
22.58K shares
Shares
−22.58K
Strike price
1.86
Held after
0.00
Exercisable
—
10/14/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Director Stock Option (right to buy) Direct | Common Stock22.58K shares | 10/14/2026 | M · Option Exercise | −22.58K | 1.86 | — | 0.00 |